Humana (NYSE:HUM) Trading 8.3% Higher – What’s Next?
by Amy Steele · The Cerbat GemHumana Inc. (NYSE:HUM – Get Free Report)’s stock price traded up 8.3% during trading on Tuesday . The stock traded as high as $295.19 and last traded at $297.0720. 1,882,361 shares traded hands during trading, a decline of 6% from the average session volume of 1,992,616 shares. The stock had previously closed at $274.26.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the company. The Goldman Sachs Group boosted their price objective on Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research note on Thursday, April 30th. Cantor Fitzgerald upped their price target on Humana from $201.00 to $264.00 in a research report on Thursday, April 30th. Wells Fargo & Company upped their price target on Humana from $206.00 to $227.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 7th. Leerink Partners upped their price target on Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a research report on Thursday, April 30th. Finally, Guggenheim upped their price target on Humana from $252.00 to $269.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. Seven investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $247.61.
View Our Latest Analysis on HUM
Humana Stock Up 7.7%
The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The business has a 50-day moving average price of $195.89 and a 200-day moving average price of $226.27. The firm has a market capitalization of $35.46 billion, a PE ratio of 31.59, a price-to-earnings-growth ratio of 2.54 and a beta of 0.68.
Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business’s revenue was up 23.5% compared to the same quarter last year. During the same period in the prior year, the business earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Equities research analysts forecast that Humana Inc. will post 9.06 earnings per share for the current fiscal year.
Humana Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. Humana’s dividend payout ratio is currently 37.86%.
Insider Buying and Selling
In other Humana news, insider Sanjay K. Shetty acquired 810 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the acquisition, the insider owned 11,657 shares of the company’s stock, valued at approximately $2,158,992.97. The trade was a 7.47% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.20% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in HUM. Illinois Municipal Retirement Fund lifted its stake in Humana by 9.6% during the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock worth $12,920,000 after purchasing an additional 4,351 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Humana by 161.5% during the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock worth $446,911,000 after purchasing an additional 1,060,767 shares in the last quarter. National Pension Service lifted its stake in Humana by 2.8% during the third quarter. National Pension Service now owns 189,601 shares of the insurance provider’s stock worth $49,328,000 after purchasing an additional 5,150 shares in the last quarter. Long Focus Capital Management LLC acquired a new position in Humana during the third quarter worth $34,212,000. Finally, Tejara Capital Ltd acquired a new position in Humana during the third quarter worth $1,873,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.